Open AccessDermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials
Author(s) -
John E Jett,
Michael J. McLaughlin,
Timothy R. Wilson,
Matthew C. Somerville,
Wayne DellaMaestra,
David A. Rubenstein,
Stephen C. Piscitelli
Publication year - 2022
Publication title -
journal of drugs in dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 62
ISSN - 1545-9616
DOI - 10.36849/jdd.6627
Subject(s) - medicine , irritation , phototoxicity , sensitization , dermatology , discontinuation , dosing , cumulative dose , clinical trial , randomized controlled trial , pharmacology , surgery , immunology , biochemistry , chemistry , in vitro